David Bassa, CEO
A leading and experienced Israeli serial entrepreneur operating in the biotech and high-tech industries (involved in over 20 companies). Led the first Cannabis pharma ‘Exit’ in Israel. CEO & Founder of the Cannabis Innovation Center. Won twice Excellence awards from the president of Israel.
Ofer Tsimchi, VP Business Development
A managing partner & co-founder of Danbar Group Ltd., Director at. Redhill Biopharma, Maabarot products and CaesarStone. Served as CEO & chairman at private and publicly traded companies Holds a B.Sc. in Economics and Agriculture from the Hebrew University, Israel.
Ofer Alshech, CFO
An experienced CFO in Public, Private, Multi-Millions & Start-Ups companies with strong organizational skills and extensive experience in financial management. Ofer has vast experience in fundraising from private equity, private investors and IPOs. Ofer has deep understanding of business drivers, risks & opportunities. For the last 8 years Ofer served as CFO at “Reshet 13” .
Guy Defrin, COO
As an experienced COO, Guy also Serves as the active COO of the Cannabis Innovation Center, including Stero Biotechs, CannaLean Biotechs, the biotech startup accelerator BioSeedXL and more in both pharmaceuticals and other biotech and Cannabis fields. Graduated B.Sc. in Biology and life sciences at Tel Aviv University with specialty in biochemistry research.
Dr. Moshe Yeshurun (MD), CTO
Specialist in Internal Medicine, Hematology and Bone Marrow Transplantation. Director of the Bone Marrow Transplantation Unit, Rabin Medical Center, Israel. The inventor of a CBD based drug and IP for treatment of GvHD, sold to the publicly traded Kalytera Therapeutics.
Dr. Sari Sagiv (PhD), Senior Scientific Advisor
Over 20 years of proven management experience in the fields of clinical development, business development, marketing and intellectual property from the bio-tech and high-tech industries. The pharma and diagnostics department at Mor Research Applications, the Technology Transfer unit of ‘CLALIT’ Health Services. Holds a PhD in immunology and an MBA from Tel Aviv University.
Prof. Moshe Mittelman (MD), Scientific & Medical Consultant
Serves as Chairman, Department of Medicine and a Hematology Consultant at the Tel Aviv Sourasky (Ichilov) Medical Center. A Professor of Medicine at Sackler School of Medicine, Tel Aviv University.. As an experienced biotech consultant, he is now Chief Medical Officer at the CannaDu investment fund, the biotech and Cannabis startup accelerator BioSeedXL and various startups in the biotech and medical fields.